These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17039264)

  • 1. Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study.
    Soucek P; Borovanova T; Pohlreich P; Kleibl Z; Novotny J
    Breast Cancer Res Treat; 2007 Jun; 103(2):219-24. PubMed ID: 17039264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N; Altinisik J; Demokan S; Dalay N
    Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
    Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
    Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
    Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
    Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
    De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
    Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
    Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
    Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
    BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A BRCA1 promoter variant (rs11655505) and breast cancer risk.
    Verderio P; Pizzamiglio S; Southey MC; Spurdle AB; Hopper JL; Chen X; Beesley J; ; Schmutzler RK; Engel C; Burwinkel B; Bugert P; Ficarazzi F; Manoukian S; Barile M; Wappenschmidt B; Chenevix-Trench G; Radice P; Peterlongo P
    J Med Genet; 2010 Apr; 47(4):268-70. PubMed ID: 20413709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.
    Figueiredo JC; Knight JA; Cho S; Savas S; Onay UV; Briollais L; Goodwin PJ; McLaughlin JR; Andrulis IL; Ozcelik H
    BMC Cancer; 2007 Jun; 7():99. PubMed ID: 17567920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.